Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia
Vascular dementia (VaD) is the second most common type of dementia following Alzheimer’s disease, but the therapeutic efficacy is still not effective. This makes the searching for novel neuroprotective agents important. Therefore, we hypothesized that royal jelly, a well-known traditional medicine,...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Food Science |
Online Access: | http://dx.doi.org/10.1155/2021/2213814 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565234315821056 |
---|---|
author | Nualpun Sirinupong Worrapanitch Chansuwan Pratchaya Kaewkaen |
author_facet | Nualpun Sirinupong Worrapanitch Chansuwan Pratchaya Kaewkaen |
author_sort | Nualpun Sirinupong |
collection | DOAJ |
description | Vascular dementia (VaD) is the second most common type of dementia following Alzheimer’s disease, but the therapeutic efficacy is still not effective. This makes the searching for novel neuroprotective agents important. Therefore, we hypothesized that royal jelly, a well-known traditional medicine, could attenuate memory impairment and brain damage in vascular dementia. This study determined the effects of royal jelly hydrolysate (RJH) and possible mechanism of cell damage and cognitive-enhancing effect in animal study. An in vitro study assessed the effects of RJH on acetylcholinesterase inhibitor, cell viability, and cell damage in SH-SY5Y neuroblastoma cells. Then, an in vivo study examined vascular dementia by the occlusion of the right middle cerebral artery (Rt.MCAO); adult male Wistar rats had been orally given RJH at doses ranging from 10, 50, to 100 mg/kg for 14 days before and 14 days after the occlusion of Rt.MCAO to mimic the VaD condition. Rats’ spatial memory was evaluated using Morris water maze and radial arm maze every 7 days after Rt.MCAO throughout a 14-day experimental period, and then, they were sacrificed and the acetylcholinesterase (AChE) activity in the hippocampus was determined. The results showed that RJH has no cytotoxic effect with the final concentration up to 500 μg protein/ml and reduces cell death from the H2O2- and glutamate-induced cell damage in in vitro neuroblastoma cells. Importantly, RJH significantly improved memory performance in Morris water maze test and radial arm maze and decreased the level of acetyl cholinesterase activity. In conclusion, RJH is the potential neuroprotective agent and cognitive enhancer for VaD. |
format | Article |
id | doaj-art-58584ebf20cd44e08408928ae1a0467a |
institution | Kabale University |
issn | 2356-7015 2314-5765 |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Food Science |
spelling | doaj-art-58584ebf20cd44e08408928ae1a0467a2025-02-03T01:08:57ZengWileyInternational Journal of Food Science2356-70152314-57652021-01-01202110.1155/2021/22138142213814Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular DementiaNualpun Sirinupong0Worrapanitch Chansuwan1Pratchaya Kaewkaen2Faculty of Agro-Industry, Prince of Songkla University, Hat Yai, Songkhla 90110, ThailandFaculty of Agro-Industry, Prince of Songkla University, Hat Yai, Songkhla 90110, ThailandCollege of Research Methodology and Cognitive Science, Burapha University, Mueang, Chonburi 20131, ThailandVascular dementia (VaD) is the second most common type of dementia following Alzheimer’s disease, but the therapeutic efficacy is still not effective. This makes the searching for novel neuroprotective agents important. Therefore, we hypothesized that royal jelly, a well-known traditional medicine, could attenuate memory impairment and brain damage in vascular dementia. This study determined the effects of royal jelly hydrolysate (RJH) and possible mechanism of cell damage and cognitive-enhancing effect in animal study. An in vitro study assessed the effects of RJH on acetylcholinesterase inhibitor, cell viability, and cell damage in SH-SY5Y neuroblastoma cells. Then, an in vivo study examined vascular dementia by the occlusion of the right middle cerebral artery (Rt.MCAO); adult male Wistar rats had been orally given RJH at doses ranging from 10, 50, to 100 mg/kg for 14 days before and 14 days after the occlusion of Rt.MCAO to mimic the VaD condition. Rats’ spatial memory was evaluated using Morris water maze and radial arm maze every 7 days after Rt.MCAO throughout a 14-day experimental period, and then, they were sacrificed and the acetylcholinesterase (AChE) activity in the hippocampus was determined. The results showed that RJH has no cytotoxic effect with the final concentration up to 500 μg protein/ml and reduces cell death from the H2O2- and glutamate-induced cell damage in in vitro neuroblastoma cells. Importantly, RJH significantly improved memory performance in Morris water maze test and radial arm maze and decreased the level of acetyl cholinesterase activity. In conclusion, RJH is the potential neuroprotective agent and cognitive enhancer for VaD.http://dx.doi.org/10.1155/2021/2213814 |
spellingShingle | Nualpun Sirinupong Worrapanitch Chansuwan Pratchaya Kaewkaen Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia International Journal of Food Science |
title | Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia |
title_full | Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia |
title_fullStr | Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia |
title_full_unstemmed | Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia |
title_short | Hydrolase-Treated Royal Jelly Attenuates H2O2- and Glutamate-Induced SH-SY5Y Cell Damage and Promotes Cognitive Enhancement in a Rat Model of Vascular Dementia |
title_sort | hydrolase treated royal jelly attenuates h2o2 and glutamate induced sh sy5y cell damage and promotes cognitive enhancement in a rat model of vascular dementia |
url | http://dx.doi.org/10.1155/2021/2213814 |
work_keys_str_mv | AT nualpunsirinupong hydrolasetreatedroyaljellyattenuatesh2o2andglutamateinducedshsy5ycelldamageandpromotescognitiveenhancementinaratmodelofvasculardementia AT worrapanitchchansuwan hydrolasetreatedroyaljellyattenuatesh2o2andglutamateinducedshsy5ycelldamageandpromotescognitiveenhancementinaratmodelofvasculardementia AT pratchayakaewkaen hydrolasetreatedroyaljellyattenuatesh2o2andglutamateinducedshsy5ycelldamageandpromotescognitiveenhancementinaratmodelofvasculardementia |